Chemoinformaics analysis of 7,8-didehydro-3- methoxy-17-methyl-6-methylene morphinan
Molecular Weight | 281.399 | nRot | 1 |
Heavy Atom Molecular Weight | 258.215 | nRig | 21 |
Exact Molecular Weight | 281.178 | nRing | 4 |
Solubility: LogS | -3.455 | nHRing | 1 |
Solubility: LogP | 3.392 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 1 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 23 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 19 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
nHA | 2 | APOL | 48.9682 |
nHD | 0 | BPOL | 26.5198 |
QED | 0.783 |
Synth | 4.687 |
Natural Product Likeliness | 1.604 |
NR-PPAR-gamma | 0.006 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.876 |
Pgp-sub | 0.001 |
HIA | 0.004 |
CACO-2 | -4.687 |
MDCK | 0.0000207 |
BBB | 0.998 |
PPB | 0.545176 |
VDSS | 3.203 |
FU | 0.392585 |
CYP1A2-inh | 0.071 |
CYP1A2-sub | 0.529 |
CYP2c19-inh | 0.083 |
CYP2c19-sub | 0.968 |
CYP2c9-inh | 0.017 |
CYP2c9-sub | 0.275 |
CYP2d6-inh | 0.974 |
CYP2d6-sub | 0.939 |
CYP3a4-inh | 0.045 |
CYP3a4-sub | 0.818 |
CL | 15.4 |
T12 | 0.182 |
hERG | 0.593 |
Ames | 0.075 |
ROA | 0.457 |
SkinSen | 0.924 |
Carcinogencity | 0.686 |
EI | 0.01 |
Respiratory | 0.967 |
NR-Aromatase | 0.022 |
Antiviral | No |
Prediction | 0.672158 |